ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI) tools ...

ICON PLC shares set higher lows in June, and the company presents strong fundamentals and economic earnings for shareholders. ICLR has shown robust financial performance, with a 9% YoY increase in ...

Icon PLC (ICLR) came out with quarterly earnings of $3.35 per share, missing the Zacks Consensus Estimate of $3.85 per share. This compares to earnings of $3.30 per share a year ago. These figures ...

Icon Plc and Medpace are both CROs, but Icon focuses on large pharma with an aggressive M&A strategy, unlike Medpace's small biotech focus. Initially impressed by Icon's financials, we purchased ...

In a market that continues to challenge even the most stalwart companies, ICON Plc (ICLR) stock has marked a new 52-week low, dipping to $227.56. This latest price level reflects the ongoing ...

ICON PLC sees FY 2024 EPS of $13.90-$14.10 versus the analyst consensus of $15.06. ICON PLC sees FY 2024 revenue of $8.26B-$8.30B versus the analyst consensus of $8.51B. ICON PLC's stock price closed ...

DUBLIN 18, Ireland (AP) — Icon PLC (ICLR) on Wednesday reported first-quarter earnings of $154.2 million. The Dublin 18, Ireland-based company said it had profit of $1.90 per share. Earnings ...